critical congenital heart disease screening saving lives one infant at a time christina rust, msn,...
TRANSCRIPT
Critical Congenital Heart Disease Screening
Saving Lives One Infant at a TimeChristina Rust, MSN, RN
• Heart disease caused by heart defects• Due to structural malformation of the heart
that forms in the early stages of cardiac development
• Normal flow of blood through the heart is disrupted
• Most common birth defect
Congenital Heart Disease (CHD)
Congenital Heart Disease (CHD)
• Affects 8 in every 1,000 live births• Approximately 40,000 U.S. births/ year• Leading cause of infant death in the
developing world• Screening provides significant opportunity
to reduce infant mortality and morbidity (MMWR, 2013)
• Heart disease caused by 7 types of cyanotic heart defects
• Can be fatal in infants if not detected and treated early
• Newborn physical assessment does
not always identify CCHD• 1999-2006 – 41,494 deaths related
to CCHD• Over 50% of deaths were infants < 12
months of age (CDC, 2011)
Critical Congenital Heart Defects (CCHD)
7 Critical Congenital Heart Defects (CCHD)
• Hypoplastic Left Heart Syndrome (HLHS)• Tetrology of Fallot • Truncus Arteriosis (TA)• Transposition of the Great Arteries (TGA)• Pulmonary Atresia • Tricuspid Atresia• Total Anomalous Pulmonary Venous Return
(TAPVR)
Screening Tool for CCHD
• Simple, painless, non-invasive pulse oximetry application
• Estimates percent of hemoglobin in the blood that is saturated with oxygen
• Pulse oximetry reading taken on the right hand and one foot
• Reading values compared to standardized algorithm (AAP and AHA)
Follow-up for CCHD
• Infants with positive screen transferred to NICU
• Placed on ECG monitoring• Assessed by NNP/Neonatologist• Echocardiogram completed• Consultation with local children’s hospial
Pediatric cardiologist
Tracking Birth Defects
• No federal population based system to track CCHD in children and adults
• States track birth defects through birth records data systems
• CDC received a grant in 2012 to establish a congenital heart disease defects database in the U.S.
• Currently trialing in Massachusetts, New York, and Atlanta, Ga.
CCHD Prevention
• Prevention research requires creation of a national database of data
- Geographic
- Demographic
- Genetic
- Environmental
- Other factors